Antireflux 'barriers': problems with patient recruitment for a new endoscopic antireflux procedure.

Standard

Antireflux 'barriers': problems with patient recruitment for a new endoscopic antireflux procedure. / Eckardt, Alexander J; Pinnow, Gernot; Pohl, Heiko; Wiedenmann, Bertram; Rösch, Thomas.

in: EUR J GASTROEN HEPAT, Jahrgang 21, Nr. 10, 10, 01.10.2009, S. 1110-1118.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

APA

Vancouver

Bibtex

@article{69c0830851bc48ff8886b39ff448012e,
title = "Antireflux 'barriers': problems with patient recruitment for a new endoscopic antireflux procedure.",
abstract = "BACKGROUND: Most first-generation endoscopic antireflux procedures (EARPs) have been withdrawn because of variable success rates, economic considerations, and/or complications. As a result, subsequent methods may meet 'skepticism' by physicians and patients. AIMS: To identify potential barriers to patient recruitment for a new EARP METHODS: We prospectively analyzed our recruitment for a phase 2 study of a transoral incisionless fundoplication procedure. We contacted 50 private practices and 23 hospitals for potential referrals, and placed three newspaper advertisements. All patient replies were followed up by a phone call. Patients were then invited for a personal interview, and eligible patients underwent further preprocedure testing. In addition, poststudy questionnaires regarding their opinions about EARPs were sent to referring physicians. RESULTS: Of 134 interviewed patients, only 10% (n=13) were successfully recruited. Candidates mostly responded to newspaper advertisements (87%) or were referred from our own institution (7%). Primary exclusion criteria included failure of proton pump inhibitor response (34%), lack of proton pump inhibitor use (20%), atypical symptoms (18%), or a large hiatal hernia (17%). Seventy percent of the responding physicians did not believe that new EARPs would be superior to previous methods. CONCLUSION: The EARP market seems to be much smaller than anticipated, partially because of skepticism of referring physicians, and partially because of strict selection criteria.",
keywords = "Adult, Germany, Humans, Male, Aged, Female, Middle Aged, Aged, 80 and over, numerical data, Young Adult, Patient Selection, Attitude to Health, Attitude of Health Personnel, Clinical Trials, Phase II as Topic methods, Fundoplication contraindications, Gastroesophageal Reflux surgery, Gastroscopy contraindications, Multicenter Studies as Topic methods, Referral and Consultation statistics, Adult, Germany, Humans, Male, Aged, Female, Middle Aged, Aged, 80 and over, numerical data, Young Adult, Patient Selection, Attitude to Health, Attitude of Health Personnel, Clinical Trials, Phase II as Topic methods, Fundoplication contraindications, Gastroesophageal Reflux surgery, Gastroscopy contraindications, Multicenter Studies as Topic methods, Referral and Consultation statistics",
author = "Eckardt, {Alexander J} and Gernot Pinnow and Heiko Pohl and Bertram Wiedenmann and Thomas R{\"o}sch",
year = "2009",
month = oct,
day = "1",
doi = "10.1097/MEG.0b013e32832937c2",
language = "English",
volume = "21",
pages = "1110--1118",
journal = "EUR J GASTROEN HEPAT",
issn = "0954-691X",
publisher = "Lippincott Williams and Wilkins",
number = "10",

}

RIS

TY - JOUR

T1 - Antireflux 'barriers': problems with patient recruitment for a new endoscopic antireflux procedure.

AU - Eckardt, Alexander J

AU - Pinnow, Gernot

AU - Pohl, Heiko

AU - Wiedenmann, Bertram

AU - Rösch, Thomas

PY - 2009/10/1

Y1 - 2009/10/1

N2 - BACKGROUND: Most first-generation endoscopic antireflux procedures (EARPs) have been withdrawn because of variable success rates, economic considerations, and/or complications. As a result, subsequent methods may meet 'skepticism' by physicians and patients. AIMS: To identify potential barriers to patient recruitment for a new EARP METHODS: We prospectively analyzed our recruitment for a phase 2 study of a transoral incisionless fundoplication procedure. We contacted 50 private practices and 23 hospitals for potential referrals, and placed three newspaper advertisements. All patient replies were followed up by a phone call. Patients were then invited for a personal interview, and eligible patients underwent further preprocedure testing. In addition, poststudy questionnaires regarding their opinions about EARPs were sent to referring physicians. RESULTS: Of 134 interviewed patients, only 10% (n=13) were successfully recruited. Candidates mostly responded to newspaper advertisements (87%) or were referred from our own institution (7%). Primary exclusion criteria included failure of proton pump inhibitor response (34%), lack of proton pump inhibitor use (20%), atypical symptoms (18%), or a large hiatal hernia (17%). Seventy percent of the responding physicians did not believe that new EARPs would be superior to previous methods. CONCLUSION: The EARP market seems to be much smaller than anticipated, partially because of skepticism of referring physicians, and partially because of strict selection criteria.

AB - BACKGROUND: Most first-generation endoscopic antireflux procedures (EARPs) have been withdrawn because of variable success rates, economic considerations, and/or complications. As a result, subsequent methods may meet 'skepticism' by physicians and patients. AIMS: To identify potential barriers to patient recruitment for a new EARP METHODS: We prospectively analyzed our recruitment for a phase 2 study of a transoral incisionless fundoplication procedure. We contacted 50 private practices and 23 hospitals for potential referrals, and placed three newspaper advertisements. All patient replies were followed up by a phone call. Patients were then invited for a personal interview, and eligible patients underwent further preprocedure testing. In addition, poststudy questionnaires regarding their opinions about EARPs were sent to referring physicians. RESULTS: Of 134 interviewed patients, only 10% (n=13) were successfully recruited. Candidates mostly responded to newspaper advertisements (87%) or were referred from our own institution (7%). Primary exclusion criteria included failure of proton pump inhibitor response (34%), lack of proton pump inhibitor use (20%), atypical symptoms (18%), or a large hiatal hernia (17%). Seventy percent of the responding physicians did not believe that new EARPs would be superior to previous methods. CONCLUSION: The EARP market seems to be much smaller than anticipated, partially because of skepticism of referring physicians, and partially because of strict selection criteria.

KW - Adult

KW - Germany

KW - Humans

KW - Male

KW - Aged

KW - Female

KW - Middle Aged

KW - Aged, 80 and over

KW - numerical data

KW - Young Adult

KW - Patient Selection

KW - Attitude to Health

KW - Attitude of Health Personnel

KW - Clinical Trials, Phase II as Topic methods

KW - Fundoplication contraindications

KW - Gastroesophageal Reflux surgery

KW - Gastroscopy contraindications

KW - Multicenter Studies as Topic methods

KW - Referral and Consultation statistics

KW - Adult

KW - Germany

KW - Humans

KW - Male

KW - Aged

KW - Female

KW - Middle Aged

KW - Aged, 80 and over

KW - numerical data

KW - Young Adult

KW - Patient Selection

KW - Attitude to Health

KW - Attitude of Health Personnel

KW - Clinical Trials, Phase II as Topic methods

KW - Fundoplication contraindications

KW - Gastroesophageal Reflux surgery

KW - Gastroscopy contraindications

KW - Multicenter Studies as Topic methods

KW - Referral and Consultation statistics

U2 - 10.1097/MEG.0b013e32832937c2

DO - 10.1097/MEG.0b013e32832937c2

M3 - SCORING: Journal article

C2 - 19300273

VL - 21

SP - 1110

EP - 1118

JO - EUR J GASTROEN HEPAT

JF - EUR J GASTROEN HEPAT

SN - 0954-691X

IS - 10

M1 - 10

ER -